BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 25004243)

  • 1. Sox9 mediates Notch1-induced mesenchymal features in lung adenocarcinoma.
    Capaccione KM; Hong X; Morgan KM; Liu W; Bishop JM; Liu L; Markert E; Deen M; Minerowicz C; Bertino JR; Allen T; Pine SR
    Oncotarget; 2014 Jun; 5(11):3636-50. PubMed ID: 25004243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of TGF-β adaptor β2SP activates notch signaling and SOX9 expression in esophageal adenocarcinoma.
    Song S; Maru DM; Ajani JA; Chan CH; Honjo S; Lin HK; Correa A; Hofstetter WL; Davila M; Stroehlein J; Mishra L
    Cancer Res; 2013 Apr; 73(7):2159-69. PubMed ID: 23536563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SOX9 drives the epithelial-mesenchymal transition in non-small-cell lung cancer through the Wnt/β-catenin pathway.
    Huang JQ; Wei FK; Xu XL; Ye SX; Song JW; Ding PK; Zhu J; Li HF; Luo XP; Gong H; Su L; Yang L; Gong LY
    J Transl Med; 2019 May; 17(1):143. PubMed ID: 31060551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SOX9 promotes epidermal growth factor receptor-tyrosine kinase inhibitor resistance via targeting β-catenin and epithelial to mesenchymal transition in lung cancer.
    Tripathi SK; Biswal BK
    Life Sci; 2021 Jul; 277():119608. PubMed ID: 33989664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Notch-1 enhances epithelial-mesenchymal transition in gefitinib-acquired resistant lung cancer cells.
    Xie M; Zhang L; He CS; Xu F; Liu JL; Hu ZH; Zhao LP; Tian Y
    J Cell Biochem; 2012 May; 113(5):1501-13. PubMed ID: 22173954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
    Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
    Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-124 inhibits cell proliferation, migration and invasion by directly targeting SOX9 in lung adenocarcinoma.
    Wang X; Liu Y; Liu X; Yang J; Teng G; Zhang L; Zhou C
    Oncol Rep; 2016 May; 35(5):3115-21. PubMed ID: 26935152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β1-SOX9 axis-inducible COL10A1 promotes invasion and metastasis in gastric cancer via epithelial-to-mesenchymal transition.
    Li T; Huang H; Shi G; Zhao L; Li T; Zhang Z; Liu R; Hu Y; Liu H; Yu J; Li G
    Cell Death Dis; 2018 Aug; 9(9):849. PubMed ID: 30154451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. sFRP1 inhibits epithelial-mesenchymal transition in A549 human lung adenocarcinoma cell line.
    Ren J; Wang R; Huang G; Song H; Chen Y; Chen L
    Cancer Biother Radiopharm; 2013 Sep; 28(7):565-71. PubMed ID: 23802127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
    Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
    Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FGF4 induces epithelial-mesenchymal transition by inducing store-operated calcium entry in lung adenocarcinoma.
    Qi L; Song W; Li L; Cao L; Yu Y; Song C; Wang Y; Zhang F; Li Y; Zhang B; Cao W
    Oncotarget; 2016 Nov; 7(45):74015-74030. PubMed ID: 27677589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glypican-5 suppresses Epithelial-Mesenchymal Transition of the lung adenocarcinoma by competitively binding to Wnt3a.
    Wang S; Qiu M; Xia W; Xu Y; Mao Q; Wang J; Dong G; Xu L; Yang X; Yin R
    Oncotarget; 2016 Nov; 7(48):79736-79746. PubMed ID: 27806326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human nonsense-mediated RNA decay regulates EMT by targeting the TGF-ß signaling pathway in lung adenocarcinoma.
    Cao L; Qi L; Zhang L; Song W; Yu Y; Xu C; Li L; Guo Y; Yang L; Liu C; Huang Q; Wang Y; Sun B; Meng B; Zhang B; Cao W
    Cancer Lett; 2017 Sep; 403():246-259. PubMed ID: 28663146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PM2.5 induces EMT and promotes CSC properties by activating Notch pathway in vivo and vitro.
    Wang Y; Zhong Y; Hou T; Liao J; Zhang C; Sun C; Wang G
    Ecotoxicol Environ Saf; 2019 Aug; 178():159-167. PubMed ID: 31002970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Notch1 is required for Kras-induced lung adenocarcinoma and controls tumor cell survival via p53.
    Licciulli S; Avila JL; Hanlon L; Troutman S; Cesaroni M; Kota S; Keith B; Simon MC; Puré E; Radtke F; Capobianco AJ; Kissil JL
    Cancer Res; 2013 Oct; 73(19):5974-84. PubMed ID: 23943799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon regulatory factor 4 (IRF4) is overexpressed in human non‑small cell lung cancer (NSCLC) and activates the Notch signaling pathway.
    Qian Y; Du Z; Xing Y; Zhou T; Chen T; Shi M
    Mol Med Rep; 2017 Nov; 16(5):6034-6040. PubMed ID: 28849037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Notch-1 and its clinical significance in different histological subtypes of human lung adenocarcinoma.
    Huang J; Song H; Liu B; Yu B; Wang R; Chen L
    J Exp Clin Cancer Res; 2013 Oct; 32(1):84. PubMed ID: 24423157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Notch Signaling Components: Diverging Prognostic Indicators in Lung Adenocarcinoma.
    Liu ZY; Wu T; Li Q; Wang MC; Jing L; Ruan ZP; Yao Y; Nan KJ; Guo H
    Medicine (Baltimore); 2016 May; 95(20):e3715. PubMed ID: 27196489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing role of Notch1 and Notch2 in a Kras(G12D)-driven murine non-small cell lung cancer model.
    Baumgart A; Mazur PK; Anton M; Rudelius M; Schwamborn K; Feuchtinger A; Behnke K; Walch A; Braren R; Peschel C; Duyster J; Siveke JT; Dechow T
    Oncogene; 2015 Jan; 34(5):578-88. PubMed ID: 24509876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Notch1 signaling regulates chondrogenic lineage determination through Sox9 activation.
    Haller R; Schwanbeck R; Martini S; Bernoth K; Kramer J; Just U; Rohwedel J
    Cell Death Differ; 2012 Mar; 19(3):461-9. PubMed ID: 21869831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.